Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The VJ Sessions aim to bring together leading experts in the oncology community to support international collaboration and allow them to discuss what the latest advances in diagnosis & therapy actually mean in the clinic.

View our growing collection of on-demand roundtable discussions across a range of oncology specialties below or listen to the podcasts on the go.

Lung Cancer

Lung Cancer

12 Oct 2023

Drug treatment of operable NSCLC

Sanjay Popat, Meenali Chitnis, Eric Lim, Riyaz Shah, Kevin Franks
29 Jun 2023

CT screening in the UK

David Baldwin, Philip Crosbie, Beth Sage, Matthew Callister, Arjun Nair
18 May 2023

How to interpret ctDNA reports

Sanjay Popat, Alastair Greystoke, Rachel Butler, Terri McVeigh, Matthew Krebs
02 Mar 2023

EGFR Exon 20 insertions - identifying and managing patients in the UK

Sanjay Popat, Riyaz Shah, Anna Minchom, Alastair Greystoke
30 Aug 2022

Highlights in Lung Cancer from WCLC 2022 with Lizza Hendriks & Tiziana VavalĂ 

Lizza Hendriks, Tiziana Vavala
Topics: the use of sotorasib in KRASG12C-mutant non-small cell lung cancer, oligometastatic disease, trial updates from WCLC 2022

06 Jun 2022

Highlights in Lung Cancer from ASCO 2022 with Jia Luo and Julia Rotow

Jia Luo, Julia Rotow
Topics: developments in the use of immunotherapy for lung cancer as well as recent trials investigating EGFR- and KRAS-mutated NSCLC.
10 Feb 2022

BTOG 2022 UK panel discussion

Sanjay Popat, Anna Minchom, Robert Rintoul, Alastair Greystoke

Topics: The current state of UK lung cancer care, novel IO targets & therapeutic cancer vaccines and the deployment of genomic testing in the UK

24 Nov 2021

EGFR-mutated NSCLC

Ross Camidge, Rosario Garcia Campelo, Natasha Leighl, Alexander Spira

Topics: Latest advances in EGFR-mutated NSCLC care including considerations around EGFR testing, first-line treatment options, immunotherapy, management of brain metastases, surveillance on therapy, reprofiling, the latest clinical trial data and what is on the horizon.

14 Oct 2021

ESMO & WCLC 2021

Sanjay Popat, Fiona McDonald, Riyaz Shah, David Baldwin

Topics: Lung cancer screening in the UK, adjuvant radiotherapy, concomitant chemo-radiation, resected NSCLC data, molecular testing, POSEIDON & HER2-mutated NSCLC

21 Jul 2021

ASCO 2021

Melissa Johnson, Heather A. Wakelee, Lizza Hendriks
Topics: IMpower010, CTONG1103 & IMPACT; CheckMate 816 & biomarkers in the adjuvant setting; KRAS G12C, HER3 ADCs and EGFR exon 20
19 May 2021

BTOG 2021

Sanjay Popat, Samreen Ahmed, David Gilligan, Neal Navani
Topics: COVID-19, SBRT & pleural effusions, KRAS inhibitors & ADCs, radiotherapy, CheckMate 816 & ADAURA
17 Feb 2021


Daniel Tan, Melissa Johnson, Dean Fennell
Topics: KRAS G12C, mesothelioma, IO & biomarkers, neoadjuvant & adjuvant strategies and screening
14 Oct 2020

ESMO 2020

Solange Peters, Martin Reck, Sanjay Popat
Topics: Oncogene targeted therapy, post-op RT in NSCLC, IO advances in NSCLC & SCLC
Breast Cancer

Breast Cancer

09 Jan 2024

Highlights from SABCS 2023 with Sara Tolaney, Paolo Tarantino & Sarah Sammons

26 Jan 2023

Highlights from SABCS 2022 with Sara Tolaney, Paolo Tarantino & Sarah Sammons

Sara M. Tolaney, Paolo Tarantino, Sarah L. Sammons
07 Oct 2022

Highlights from ESMO 2022 with Elisa Agostinetto & Evandro de Azambuja


06 Jun 2022

Examining DESTINY-Breast04 with Matteo Lambertini & Evandro de Azambuja

Matteo Lambertini, Evandro de Azambuja
Topics: Trial updates in the field of ADCs and CDK4/6 inhibitors
06 Jun 2022

Latest updates from ASCO 2022 with Paolo Tarantino & Romualdo Barroso

Paolo Tarantino, Romualdo Barroso
Topics: results from the MAINTAIN trial, TROPiCS, and antibody-drug conjugates such as patritumab deruxtecan and trastuzumab deruxtecan.
19 May 2022

Updates in TNBC with Roberto Salgado & Marleen Kok

Marleen Kok, Roberto Salgado

Topics: Treatment de-escalation, biomarkers and TILs

14 Jan 2022

Highlights from SABCS 2021 with Hope Rugo & Dave Cescon

Hope Rugo, Dave Cescon

Topics: KEYNOTE-522, KEYNOTE-355; EMERALD, and more IO updates at SABCS

21 Dec 2021

Highlights from SABCS 2021 with Lisa Carey & Aleix Prat

Topics: KEYNOTE-522, KEYNOTE-355; NIMBUS, and more IO updates at SABCS

16 Dec 2021

Immunotherapy updates at SABCS 2021

Topics: KEYNOTE-522, KEYNOTE-355; NIMBUS, and more IO updates at SABCS

28 Sep 2021

ESMO 2021

Matteo Lambertini, Evandro de Azambuja
Topics: DESTINY-Breast 03 & TULIP, MONALEESA2 & GIM4 and BrighTNess
30 Jun 2021

ASCO 2021

Erika Hamilton, Giuseppe Curigliano, Sara Tolaney, Andrew Tutt

Topics: OlympiA & olaparib, capecitabine, GeparNuevo & BEGONIA, CDK4/6, SERDs, BCL-2 & talazoparib

22 Apr 2021

St. Gallen Consensus 2021

Giuseppe Curigliano, Fatima Cardoso, Lisa Carey, Hope Rugo

Topics: pCR & IO, carboplatin & olaparib, gene signature assays & CDK4/6 inhibitors

26 Jan 2021

SABCS 2020

Erika Hamilton, Matteo Lambertini, Sibylle Loibl

Topics: CDK4/6 inhibitors, RxPONDER & premenopausal pts, IO and more SABCS highlights

GU Cancers

GU Cancers

16 Mar 2023

Radiotherapy Highlights from ASCO GU 2023 with Sophia Kamran, Himanshu Nagar, and Neha Vapiwala

Sophia Kamran, Himanshu Nagar, Neha Vapiwala

Topics: RADICALS-HD, FORMULA-509, and adaptive radiotherapy

15 Mar 2023

Key Trials from ASCO GU 2023 with Scott Tagawa, Karie Runcie, and Tanya Dorff

Scott T. Tagawa, Karie Runcie, Tanya Dorff

Topics: TRITON3, TALAPRO-2, TROPHY-U-01, COSMIC-313, & CheckMate 9ER

10 Mar 2022

ASCO GU Cancers Symposium 2022

Tian Zhang, Scott Tagawa

Topics: PROpel, MAGNITUDE & ARASENS in prostate cancer and NEOAVAX, KN-564 and axitinib plus nivo in renal cell carcinoma